Laurel Therapeutics Ltd.
Records under this name other than the patents Laurel Therapeutics Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 10 of 10 · Back to Laurel Therapeutics Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,673,961 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents Lapsed on the fee record Ended Mar 18, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 18, 2026 | From the USPTO record |
| US 9,856,219 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors Lapsed on the fee record Ended Jan 2, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 2, 2026 | From the USPTO record |
| US 9,814,700 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents Lapsed on the fee record Ended Nov 14, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 14, 2025 | From the USPTO record |
| US 9,498,466 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents Lapsed on the fee record Ended Nov 22, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 22, 2024 | From the USPTO record |
| US 9,433,618 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors Lapsed on the fee record Ended Sep 6, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 6, 2024 | From the USPTO record |
| US 9,315,462 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors Lapsed on the fee record Ended Apr 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 19, 2024 | From the USPTO record |
| US 9,180,119 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents Lapsed on the fee record Ended Nov 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 10, 2023 | From the USPTO record |
| US 9,139,528 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors Lapsed on the fee record Ended Sep 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 22, 2023 | From the USPTO record |
| US 10,399,946 | Solid forms of an S-Nitrosoglutathione reductase inhibitor Lapsed on the fee record Ended Sep 3, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 3, 2023 | From the USPTO record |
| US 8,957,105 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents Lapsed on the fee record Ended Feb 17, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 17, 2023 | From the USPTO record |